BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26335364)

  • 1. Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
    Morishita S; Tomita K; Ono T; Murakoshi M; Saito K; Sugiyama K; Nishino H; Kato H
    Biochem Cell Biol; 2015 Dec; 93(6):566-73. PubMed ID: 26335364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.
    Im AR; Kim YH; Lee HW; Song KH
    J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line.
    Lee SH; Park SW; Pyo CW; Yoo NK; Kim J; Choi SY
    Biochimie; 2009 Jan; 91(1):102-8. PubMed ID: 18534198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
    Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
    Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway.
    Zhang Y; Chen ML; Zhou Y; Yi L; Gao YX; Ran L; Chen SH; Zhang T; Zhou X; Zou D; Wu B; Wu Y; Chang H; Zhu JD; Zhang QY; Mi MT
    Mol Nutr Food Res; 2015 Aug; 59(8):1443-57. PubMed ID: 25943029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotective Effect of Loquat Leaf Flavonoids in PM
    Jian T; Ding X; Wu Y; Ren B; Li W; Lv H; Chen J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis by AKT, eNOS, p38 MAPK, and JNK pathways.
    Yuan L; Lu CL; Wang Y; Li Y; Li XY
    J Diabetes Res; 2014; 2014():391476. PubMed ID: 24804268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Foxo1 mediates protective effects of ghrelin against lipotoxicity in MIN6 pancreatic beta-cells.
    Wang W; Liu Y; Chen Y; Cao C; Xiang Y; Zhang D; Han L; Zhao H; Liu G
    Peptides; 2010 Feb; 31(2):307-14. PubMed ID: 19944124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
    Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
    J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
    Imarisio C; Alchera E; Sutti S; Valente G; Boccafoschi F; Albano E; Carini R
    Clin Sci (Lond); 2012 Sep; 123(5):323-32. PubMed ID: 22439844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
    Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
    Wang H; Huang M; Bei W; Yang Y; Song L; Zhang D; Zhan W; Zhang Y; Chen X; Wang W; Wang L; Guo J
    Biomed Pharmacother; 2021 Jun; 138():111532. PubMed ID: 34311531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase.
    Choi YJ; Suh HR; Yoon Y; Lee KJ; Kim DG; Kim S; Lee BH
    Arch Pharm Res; 2014; 37(9):1169-76. PubMed ID: 24633463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin receptor 1 enhances fatty acid metabolism and cell survival in palmitate-treated HepG2 cells through the PI3 K/AKT pathway.
    Chou IP; Lin YY; Ding ST; Chen CY
    Eur J Nutr; 2014 Apr; 53(3):907-17. PubMed ID: 24129500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease.
    Pang L; Liu K; Liu D; Lv F; Zang Y; Xie F; Yin J; Shi Y; Wang Y; Chen D
    Cell Death Dis; 2018 Jan; 9(2):90. PubMed ID: 29367738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
    Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin induces tropoelastin expression by activating the lipoprotein receptor-related protein 1-mediated phosphatidylinositol 3-kinase/Akt pathway in human dermal fibroblasts.
    Ryu M; Nogami A; Kitakaze T; Harada N; Suzuki YA; Yamaji R
    Cell Biol Int; 2017 Dec; 41(12):1325-1334. PubMed ID: 28833753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
    Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.